bioAffinity, Pictor Collaborate on Asthma and COPD Tests
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
A large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Research using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.
Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.